Europe has approved a new indication for sorafenib tosylate tablets (Nexavar) and an expanded indication for darbepoetin alfa (Aranesp); Japan has approved idursulfase solution (Elaprase). Medscape Medical News
CDC analyzed cancer death rates among children (defined as aged 0--14 years) and adolescents (defined as aged 15--19 years) for the period 1990--2004 Morbidity & Mortality Weekly Report
In this Expert Interview from ASH 2007, Dr. Jorge Cortes discusses new and follow-up data from clinical trials of drug therapies for CML. Medscape Hematology-Oncology